ArticleClinical case reports2026
Bullous Pemphigoid in Children: Sustained 8-Year Remission After Short-Course Corticosteroid Therapy.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bullous Pemphigoid in Children: Sustained 8-Year Remission After Short-Course Corticosteroid Therapy.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article reports a case of bullous pemphigoid (BP) in a 5-year-old child who achieved sustained remission for up to 8 years following short-course systemic corticosteroid therapy, aiming to provide observational evidence for the clinical management of childhood BP. The child initially presented with pruritic rashes and blisters, which were once misdiagnosed as infectious rashes; finally, the diagnosis was confirmed by direct immunofluorescence (DIF), histopathology, and other examinations. After treatment with systemic glucocorticoids combined with anti-infective therapy, the skin lesions basically resolved within 2 weeks, and the tapering and discontinuation of drugs were completed within 26 weeks of treatment. During the 8-year follow-up period, no recurrence or treatment-related complications were observed. This case suggests that although childhood BP is prone to misdiagnosis, it responds well to glucocorticoid treatment, and long-term remission can be achieved with a relatively short treatment course; however, this model still needs to be verified by large-sample studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.